Citation Impact
Citing Papers
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Polymorphonuclear neutrophils from human immunodeficiency virus- infected patients show enhanced activation, diminished fMLP-induced L- selectin shedding, and an impaired oxidative burst after cytokine priming
1994
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Relationship between the Size of the Human Immunodeficiency Virus Type 1 (HIV‐1) Reservoir in Peripheral Blood CD4+T Cells and CD4+:CD8+T Cell Ratios in Aviremic HIV‐1–Infected Individuals Receiving Long‐Term Highly Active Antiretroviral Therapy
2002
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Syndemics and the biosocial conception of health
2017 Standout
Neonatal risk factors for cerebral palsy in very preterm babies: case-control study
1997
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy
1990
Coinfection with Herpes Simplex Virus Type 2 Is Associated with Reduced HIV‐Specific T Cell Responses and Systemic Immune Activation
2008
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
2010 Standout
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
1999
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
1998 StandoutNobel
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
VHL and p53: Tumor Suppressors Team Up to Prevent Cancer
2006 StandoutNobel
AIDS pathogenesis: a dynamic interaction between HIV and the immune system
1990
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Chorioamnionitis as a Risk Factor for Cerebral Palsy
2000 Standout
Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium
1998
The P53 pathway: what questions remain to be explored?
2006
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
Elevated CD38 Antigen Expression on CD8+ T Cells Is a Stronger Marker for the Risk of Chronic HIV Disease Progression to AIDS and Death in the Multicenter AIDS Cohort Study Than CD4+ Cell Count, Soluble Immune Activation Markers, or Combinations of HLA-DR and CD38 Expression
1997
Air pollution and health
2002 Standout
p53 in health and disease
2007 Standout
HIV as the cause of AIDS
1996 StandoutNobel
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls
1999 Standout
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Cd8+ Lymphocyte Activation At Human Immunodeficiency Virus Type 1 Seroconversion: Development Of Hla-Dr+ Cd38- Cd8+ Cells Is Associated With Subsequent Stable Cd4+ Cell Levels
1994
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir
1996
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
Comparative analysis of apoptosis in HIV-infected humans and chimpanzees: relation with lymphocyte activation
1996
Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection
1996
Effects of repeated exposure to 4 ppm nitrogen dioxide on bronchoalveolar lymphocyte subsets and macrophages in healthy men
1992
In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals
1995 StandoutNobel
Gut Microbiota in Health and Disease
2010 Standout
Human Immunodeficiency Virus Induces a Dual Regulation of Bcl-2, Resulting in Persistent Infection of CD4+T- or Monocytic Cell Lines
1998 StandoutNobel
The Anti-inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65
1998 Standout
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.
1996 Standout
Gamma Interferon-Mediated Inflammation Is Associated with Lack of Protection from Intravaginal Simian Immunodeficiency Virus SIVmac239 Challenge in Simian-Human Immunodeficiency Virus 89.6-Immunized Rhesus Macaques
2003
T cell activation and disease severity in HIV infection
1993
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
1994 Standout
Role of Antibiotics and Fungal Microbiota in Driving Pulmonary Allergic Responses
2004
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease
1997 StandoutNobel
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Pathogenesis of human immunodeficiency virus infection
1993
Thymocyte-Thymic Epithelial Cell Interaction Leads to High-Level Replication of Human Immunodeficiency Virus Exclusively in Mature CD4+CD8−CD3+Thymocytes: a Critical Role for Tumor Necrosis Factor and Interleukin-7
1999 StandoutNobel
Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection
2005
Redox and Activation Status of Monocytes from Human Immunodeficiency Virus-Infected Patients: Relationship with Viral Load
1999
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Ischemic Cell Death in Brain Neurons
1999 Standout
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
1992
Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro
1994 StandoutNobel
Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids
1994 StandoutNobel
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Antigenic Diversity Thresholds and the Development of AIDS
1991 Science
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.
1996 StandoutNobel
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex.
1990
Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion
2007
Changes in natural immunity during the course of HIV-1 infection
1993
Flow-mediated endothelial mechanotransduction
1995 Standout
Works of M. Levacher being referenced
Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicity.
1986
Prospective Study of CD8 + Lymphocyte Activation in Relation to Viral Load in HIV-Infected Patients with >=400 CD4 + Lymphocytes per Microliter
1999
EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
1988
High levels of endogenous nitric oxide produced after burn injury in rats arrest activated T lymphocytes in the first G1 phase of the cell cycle and then induce their apoptosis
2005
Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy
1998
Beta-lactam antibiotics and human lymphocyte function: The in vitro effect on blastogenesis, lymphokine production and suppressor cell functions
1987
T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS
1990
The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value
1992
Humoral immunodepression following acute No2exposure in normal and adrenalectomized mice
1985